Newsletter Subject

[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

From

marketsectordaily.com

Email Address

editor@marketsectordaily.com

Sent On

Thu, Nov 24, 2022 04:29 PM

Email Preheader Text

Stocks with 5 days of consecutive price advances. --------------------------------------------------

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- Sponsor Message [The White House Just Declared War Against the Dollar]() The White House has just declared war — on the U.S. dollar ... igniting a terrifying new crisis that goes much deeper than our currency. Millions of unsuspecting folks will see their wealth and civil rights vanish — but those who [watch this video]() will have the opportunity to escape the coming carnage virtually unscathed. [I urge you to see Ian King’s controversial message right away.]() --------------------------------------------------------------- November 24, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [A $226B Copper Spending Jackpot]( =On November 15, 2021, President Biden signed the biggest infrastructure spending bill of all time. A staggering $226 BILLION is earmarked for projects requiring huge amounts of copper. Turns out, copper is a desperately needed mineral to power the green revolution of clean, renewable energy. [See Who Can Benefit From this Government-backed Initiative.](=) --------------------------------------------------------------- [Puma Biotechnology, PBYI]( Recent Analyst Action: Edward White, analyst at H.C. Wainwright, reiterates coverage on [Puma Biotechnology (PBYI)]()in the Healthcare sector with a Buy rating and a price target of $8.00 (2 weeks ago). - Recent Price: $4.73 - Average Analyst Price Target: $8.00 (69.13%) - Market Cap: $215.88M [TipRanks.com]( also reports that [Puma Biotechnology](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $8.00 down to a low forecast of $8.00. [Puma Biotechnology (PBYI)]()’s last closing price was $4.73 which would put the average price target at $8.00. Here are 3rd party ratings for [PBYI](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 22% (55 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [These 2 Dividend Stocks Pay Every Week]() Are you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week]()- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.]() = --------------------------------------------------------------- [Clearfield, CLFD]() Recent Analyst Action: Tim Savageaux, analyst at Northland Securities, reiterates coverage on [Clearfield (CLFD)]()in the Technology sector with a Buy rating and a price target of $120.00 (6 days ago). - Recent Price: $129.5 - Average Analyst Price Target: $130.00 (0.39%) - Market Cap: $1.78B [TipRanks.com]( also reports that [Clearfield](=)currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $130.00. The target pricing ranges from a high forecast of $135.00 down to a low forecast of $120.00. [Clearfield (CLFD)](=)’s last closing price was $129.5 which would put the average price target at $130.00. Here are 3rd party ratings for [CLFD](): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Bottom 41% (148 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- [Polestar Automotive Holding UK, PSNY]( Recent Analyst Action: Itay Michaeli, analyst at Citigroup, reiterates coverage on [Polestar Automotive Holding UK (PSNY)](in the Consumer Goods sector with a Buy rating and a price target of $12.00 (1 week ago). - Recent Price: $7.87 - Average Analyst Price Target: $10.50 (33.42%) - Market Cap: $3.68B [TipRanks.com]( also reports that [Polestar Automotive Holding UK]()currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $10.50. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $9.00. [Polestar Automotive Holding UK (PSNY)](’s last closing price was $7.87 which would put the average price target at $10.50. Here are 3rd party ratings for [PSNY](): - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Millionaire Investor Reveals: "How I Made My Second Fortune... By Avoiding 99% of Stocks"]( this small group of unique stocks… never sell them… and make all the money you need… No matter what happens in the market. [Revealed here: the name and ticker of the #1 stock.](=) = --------------------------------------------------------------- [American Eagle, AEO](=) Recent Analyst Action: Paul Lejuez, analyst at Citigroup, reiterates coverage on [American Eagle (AEO)]()in the Consumer Goods sector with a Hold rating and a price target of $17.00 (1 day ago). - Recent Price: $15.8 - Average Analyst Price Target: $14.90 (-5.70%) - Market Cap: $2.96B [TipRanks.com]( also reports that [American Eagle](=)currently has 10 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $14.90. The target pricing ranges from a high forecast of $17.00 down to a low forecast of $12.00. [American Eagle (AEO)](’s last closing price was $15.8 which would put the average price target at $14.90. Here are 3rd party ratings for [AEO](=): - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 44% (140 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- [Ikena Oncology, IKNA](=) Recent Analyst Action: Robert Burns, analyst at H.C. Wainwright, reiterates coverage on [Ikena Oncology (IKNA)](=)in the Healthcare sector with a Buy rating and a price target of $26.00 (6 days ago). - Recent Price: $2.56 - Average Analyst Price Target: $22.00 (759.38%) - Market Cap: $92.82M [TipRanks.com]( also reports that [Ikena Oncology](=)currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $22.00. The target pricing ranges from a high forecast of $26.00 down to a low forecast of $18.00. [Ikena Oncology (IKNA)](’s last closing price was $2.56 which would put the average price target at $22.00. Here are 3rd party ratings for [IKNA](=): - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 22% (55 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"](=) = [Click here]( for the name of the one ticker you need to protect yourself. = --------------------------------------------------------------- [BioVie, BIVI]() Recent Analyst Action: Constantine Davides, analyst at EF Hutton, reiterates coverage on [BioVie (BIVI)]()in the Healthcare sector with a Buy rating and a price target of $8.00 (1 month ago). - Recent Price: $6.12 - Average Analyst Price Target: $10.00 (63.40%) - Market Cap: $186.86M [TipRanks.com](=) also reports that [BioVie](=)currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $8.00. [BioVie (BIVI)]()’s last closing price was $6.12 which would put the average price target at $10.00. Here are 3rd party ratings for [BIVI](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 32% (81 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- [Allego, ALLG](=) Recent Analyst Action: Matt Summerville, analyst at D.A. Davidson, reiterates coverage on [Allego (ALLG)](in the Consumer Goods sector with a Buy rating and a price target of $10.00 (1 week ago). - Recent Price: $4.08 - Average Analyst Price Target: $8.00 (96.08%) - Market Cap: $1.09B [TipRanks.com](=) also reports that [Allego](=)currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $4.00. [Allego (ALLG)](’s last closing price was $4.08 which would put the average price target at $8.00. Here are 3rd party ratings for [ALLG](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Hold, Bottom 42% (145 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Fed Exposed! Former government insider tells ALL Secret plan to destroy the markets?](=) =This [former government insider](=) just went on LIVE camera and exposed the Federal Reserve for what it REALLY is… An institution created in secret designed to rob you of your savings, and destroy your wealth. And even though we all know these central bankers have blood on their hands (inflation, the Greenspan bubble, Ben Bernanke)… No one, and I mean NO ONE expected [this](=). If what this insider says is correct, you may only have days to prepare. [Click here to see his shocking exposé.]( = --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketSectorDaily.com [Unsubscribe]() Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States (877) 411-9808

Marketing emails from marketsectordaily.com

View More
Sent On

09/05/2024

Sent On

09/05/2024

Sent On

09/05/2024

Sent On

09/05/2024

Sent On

08/05/2024

Sent On

08/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.